PGR Gene Fusions Identify a Molecular Subset of Uterine Epithelioid Leiomyosarcoma With Rhabdoid Features
暂无分享,去创建一个
C. Antonescu | G. Turashvili | E. Oliva | B. Dickson | R. Murali | R. Soslow | M. Hensley | Yun‐Shao Sung | D. Swanson | Lei Zhang | S. Chiang | C. Stewart | Wesley R. Samore | C. Stewart
[1] S. Yip,et al. Novel EPC1 gene fusions in endometrial stromal sarcoma , 2018, Genes, chromosomes & cancer.
[2] A. Drilon,et al. Repotrectinib (TPX-0005) Is a Next-Generation ROS1/TRK/ALK Inhibitor That Potently Inhibits ROS1/TRK/ALK Solvent- Front Mutations. , 2018, Cancer discovery.
[3] M. Köbel,et al. ALK Is a Specific Diagnostic Marker for Inflammatory Myofibroblastic Tumor of the Uterus , 2018, The American journal of surgical pathology.
[4] M. Ladanyi,et al. NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma , 2018, The American journal of surgical pathology.
[5] L. Gorunova,et al. Identification of an EPC2-PHF1 fusion transcript in low-grade endometrial stromal sarcoma , 2018, Oncotarget.
[6] K. Giannikou,et al. Expanding the histomorphologic spectrum of TFE3-rearranged perivascular epithelioid cell tumors. , 2018, Human pathology.
[7] Funda Meric-Bernstam,et al. Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children , 2018, The New England journal of medicine.
[8] C. Antonescu,et al. Uterine PEComas: A Morphologic, Immunohistochemical, and Molecular Analysis of 32 Tumors , 2018, The American journal of surgical pathology.
[9] J. Fletcher,et al. BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas , 2017, The American journal of surgical pathology.
[10] M. Ladanyi,et al. ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity , 2017, Modern Pathology.
[11] Y. Ishikawa,et al. Dramatic response to alectinib in inflammatory myofibroblastic tumor with anaplastic lymphoma kinase fusion gene. , 2017, Japanese journal of clinical oncology.
[12] A. Chou,et al. Inflammatory Myofibroblastic Tumors of the Female Genital Tract Are Under-recognized , 2017, The American journal of surgical pathology.
[13] E. Oliva,et al. Inflammatory myofibroblastic tumor of the uterus: a clinicopathological, immunohistochemical, and molecular analysis of 13 cases highlighting their broad morphologic spectrum , 2017, Modern Pathology.
[14] M. Ladanyi,et al. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology , 2017, Modern Pathology.
[15] Jen-Chieh Lee,et al. Uterine Inflammatory Myofibroblastic Tumors Frequently Harbor ALK Fusions With IGFBP5 and THBS1 , 2017, The American journal of surgical pathology.
[16] A. D. Dei Tos,et al. HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma , 2017, Genes, chromosomes & cancer.
[17] A. Chinnaiyan,et al. Next generation sequencing of extraskeletal myxoid chondrosarcoma , 2017, Oncotarget.
[18] Xiaoyu Chen,et al. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications , 2016, Bioinform..
[19] Adrian V. Lee,et al. Comprehensive evaluation of fusion transcript detection algorithms and a meta-caller to combine top performing methods in paired-end RNA-seq data , 2015, Nucleic acids research.
[20] Narasimhan P. Agaram,et al. Dichotomy of Genetic Abnormalities in PEComas With Therapeutic Implications , 2015, The American journal of surgical pathology.
[21] M. Hameed,et al. TFE3 Translocation–associated Perivascular Epithelioid Cell Neoplasm (PEComa) of the Gynecologic Tract: Morphology, Immunophenotype, Differential Diagnosis , 2015, The American journal of surgical pathology.
[22] D. Bell,et al. High-grade Endometrial Stromal Sarcomas: A Clinicopathologic Study of a Group of Tumors With Heterogenous Morphologic and Genetic Features , 2014, The American journal of surgical pathology.
[23] Rama R. Gullapalli,et al. Extraskeletal myxoid chondrosarcoma with a t(9;16)(q22;p11.2) resulting in a NR4A3-FUS fusion. , 2014, Cancer genetics.
[24] P. Picci,et al. Diagnostic utility of molecular investigation in extraskeletal myxoid chondrosarcoma. , 2014, The Journal of molecular diagnostics : JMD.
[25] Samuel Singer,et al. Extraskeletal myxoid chondrosarcoma with non-EWSR1-NR4A3 variant fusions correlate with rhabdoid phenotype and high-grade morphology. , 2014, Human pathology.
[26] R. Sciot,et al. Identification of a novel, recurrent MBTD1‐CXorf67 fusion in low‐grade endometrial stromal sarcoma , 2014, International journal of cancer.
[27] P. D. Dal Cin,et al. Perivascular Epithelioid Cell Neoplasm (PEComa) of the Gynecologic Tract: Clinicopathologic and Immunohistochemical Characterization of 16 Cases , 2014, The American journal of surgical pathology.
[28] B. Bjerkehagen,et al. Fusion of the ZC3H7B and BCOR genes in endometrial stromal sarcomas carrying an X;22‐translocation , 2013, Genes, chromosomes & cancer.
[29] Joshua M. Stuart,et al. Integrated genomic characterization of endometrial carcinoma , 2013, Nature.
[30] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.
[31] B. Bjerkehagen,et al. Novel Fusion of MYST/Esa1-Associated Factor 6 and PHF1 in Endometrial Stromal Sarcoma , 2012, PloS one.
[32] M. van de Rijn,et al. The Clinicopathologic Features of YWHAE-FAM22 Endometrial Stromal Sarcomas: A Histologically High-grade and Clinically Aggressive Tumor , 2012, The American journal of surgical pathology.
[33] Steven J. M. Jones,et al. 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma , 2012, Proceedings of the National Academy of Sciences.
[34] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[35] E. Oliva,et al. Smooth muscle tumors of the uterus: a practical approach. , 2009, Archives of pathology & laboratory medicine.
[36] N. Wake,et al. Endometrial Stromal Sarcomas and Related High-grade Sarcomas: Immunohistochemical and Molecular Genetic Study of 31 Cases , 2008, The American journal of surgical pathology.
[37] J. Albores–Saavedra,et al. HMB-45 Reactivity in Conventional Uterine Leiomyosarcomas , 2007, The American journal of surgical pathology.
[38] A. Chlumská,et al. HMB45+ cells in mixed stromal‐smooth muscle tumour of the uterus , 2006, Histopathology.
[39] M. Michal,et al. HMB45+ Hyalinized Epithelioid Tumor of the Uterus Is Linked to Epithelioid Leiomyoma Rather Than to PEC-omas , 2001, International journal of surgical pathology.
[40] J. Goldblum,et al. Epithelioid smooth-muscle tumors of the uterus: a clinicopathologic study of 18 patients. , 1997, The American journal of surgical pathology.
[41] R. Kurman,et al. Mesenchymal tumors of the uterus VI. Epithelioid smooth muscle tumors including leiomyoblastoma and clear‐cell leiomyoma. A clinical and pathologic analysis of 26 cases , 1976, Cancer.
[42] C. Kunder,et al. ALK-rearranged Tumors Are Highly Enriched in the STUMP Subcategory of Uterine Tumors , 2019, The American journal of surgical pathology.
[43] C. Antonescu,et al. Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma , 2017, The American journal of surgical pathology.
[44] A. Folpe,et al. Perivascular epithelioid cell neoplasms: pathology and pathogenesis. , 2010, Human pathology.
[45] B. Bjerkehagen,et al. Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma. , 2006, Cancer research.
[46] P. Clement,et al. Epithelioid endometrial and endometrioid stromal tumors: a report of four cases emphasizing their distinction from epithelioid smooth muscle tumors and other oxyphilic uterine and extrauterine tumors. , 2002, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.